Researchers reduce inflammation in human cells, a major cause of frailty

November 2, 2015

Chronic inflammation, closely associated with frailty and age-related diseases, is a hallmark of aging. Mayo Clinic researchers have discovered that inhibiting key enzyme pathways reduces inflammation in human cells in culture dishes and decreases inflammation and frailty in aged mice. The results appear today in Proceedings of the National Academy of Sciences of the United States of America. While further studies are needed, researchers are hopeful that these findings will be a step toward treatments for frailty and other age-related chronic conditions.

In the study, researchers found that Janus kinase (JAK) inhibitors, drugs that work to block activity of JAK enzymes, decreased the factors released by human in culture dishes. Senescent cells are cells that contribute to and diseases associated with aging. Also, these same JAK inhibitors reduced inflammatory mediators in mice. Researchers examined aged mice, equivalent to 90-year-old people, before and after JAK inhibitors. Over the course of two months, the researchers found substantial improvement in the physical function of the aged mice, including grip strength, endurance and physical activity.

"One of the things we want to do is find some kind of treatment for this other than prescribing better wheelchairs or walkers, or other kinds of things that we are stuck with now that are Band-Aid solutions," says James Kirkland, M.D., Ph.D., director of the Mayo Clinic Robert and Arlene Kogod Center on Aging and senior author of the study. A clinical geriatrician, Dr. Kirkland says he sees frailty in many of his elderly patients and that it's often associated with poor outcomes and functional disability.

"Our goal is not necessarily to increase , and certainly not life span at all costs. Our goal is to enhance health span—the period during life when people are independent," explains Dr. Kirkland. "This drug approach and others we are developing look like they might hold some promise in reaching that goal."

Explore further: Blocking enzymes in hair follicles promotes hair growth

More information: JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1515386112

Related Stories

Blocking enzymes in hair follicles promotes hair growth

October 23, 2015

Inhibiting a family of enzymes inside hair follicles that are suspended in a resting state restores hair growth, a new study from researchers at Columbia University Medical Center has found. The research was published today ...

Scientists find class of drugs that boosts healthy lifespan

March 9, 2015

A research team from The Scripps Research Institute (TSRI), Mayo Clinic and other institutions has identified a new class of drugs that in animal models dramatically slows the aging process—alleviating symptoms of frailty, ...

Researchers discover tactic to delay age-related disorders

November 2, 2011

Researchers at Mayo Clinic have shown that eliminating cells that accumulate with age could prevent or delay the onset of age-related disorders and disabilities. The study, performed in mouse models, provides the first evidence ...

Fitness and frailty in adults linked to health outcomes

April 26, 2011

The prevalence of frailty, which is linked to earlier death, increases throughout adulthood as people age and not just after age 65, found an article in CMAJ (Canadian Medical Association Journal). Relatively good fitness ...

Recommended for you

Researchers find piece in inflammatory disease puzzle

May 23, 2017

Inflammation is the process by which the body responds to injury or infection but when this process becomes out of control it can cause disease. Monash Biomedicine Discovery Institute (BDI) researchers, in collaboration with ...

Study offers new insight into powerful inflammatory regulator

May 1, 2017

A new study in mice reveals how a protein called Brd4 boosts the inflammatory response—for better and for worse, depending on the ailment. The study is the first to show that this protein, while problematic in some circumstances, ...

Researchers find molecular trigger for brain inflammation

April 27, 2017

Brain inflammation is a key component of multiple sclerosis, Alzheimer's, Parkinson's, ALS, and most other major neurodegenerative diseases. How inflammation starts, how it's sustained, and how it contributes to these diseases ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.